Martin G. Larson

Martin G. Larson, SD, is a distinguished expert in biostatistics and public health with significant contributions to cardiovascular research. As the Co-Principal Investigator of the Framingham Heart Study, he has been instrumental in advancing the understanding of cardiovascular disease and its risk factors. Dr. Larson holds multiple academic positions at Boston University, serving as a Research Professor in the School of Public Health's Department of Biostatistics, the Department of Mathematics and Statistics, and the Chobanian & Avedisian School of Medicine. His work focuses on critical areas such as hypertension, atrial fibrillation, heart failure, and arterial stiffness. Dr. Larson's research has led to groundbreaking insights into biomarkers, including natriuretic peptides, and their role in cardiovascular health. His expertise extends to blood pressure regulation, thrombosis, and coronary artery disease, making him a leading authority in his field. Based in Framingham, Massachusetts, Dr. Larson’s work has garnered international recognition, with high rankings in public health and biostatistics. His efforts have significantly shaped the scientific understanding of cardiovascular health and disease prevention, influencing clinical practices and public health policies worldwide. Dr. Larson’s dedication to advancing cardiovascular research underscores his pivotal role in improving global health outcomes.